Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000123512 | SCV000166850 | benign | not specified | 2014-05-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001469175 | SCV001673247 | likely benign | Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy | 2023-11-27 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001798410 | SCV002042956 | likely benign | Cardiomyopathy | 2020-03-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381434 | SCV002693076 | likely benign | Cardiovascular phenotype | 2021-07-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |